Speaker Profile
M.D., Ph.D., Professor of Medicine, MD Anderson Cancer Ctr.
Biography
Dr. Tsimberidou has designed highly innovative clinical trials that have changed the standard of practice of oncology in patients with solid tumors and hematologic malignancies. She pioneered the personalized medicine program for advanced cancer at MD Anderson Cancer Center, demonstrating that identification of molecular aberrations and selection of therapy based on tumor abnormalities is associated with improved clinical outcomes compared with standard approaches. She is leading IMPACT2, a randomized trial in precision oncology, and personalized immunotherapy trials. She has published 280 articles in highimpact peerreviewed journals. She has been invited to present her work as a keynote speaker at numerous national and international conferences. She has received various prestigious awards including a Career Development Award from ASCO. She chaired ASCOs Clinical Research Committee (20162017) and serves on various ASCO committees. Her highquality innovative research focuses on development and implementation of precision oncology through innovative therapeutic approaches, education, and patient care.
Clinical Dx Showcase:
MD Anderson Cancer Ctr.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative
